Results 181 to 190 of about 4,239 (207)

Ibrutinib and standard immunochemotherapy in younger, high‐risk patients with diffuse large B‐cell lymphoma: A phase II study of GLA

open access: yesBritish Journal of Haematology, EarlyView.
Summary Younger patients with high‐risk diffuse large B‐cell lymphoma (DLBCL) frequently have unfavourable outcomes. We conducted a prospective phase II study evaluating ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R‐CHOEP+I) in patients aged 18–60 years with DLBCL and age‐adjusted international prognostic index ≥2.
Evgenii Shumilov   +19 more
wiley   +1 more source

A SWOT Analysis of Three Programmes for Persons With Intellectual Disabilities in Higher Education Settings in Chile, Ireland and Australia

open access: yesBritish Journal of Learning Disabilities, EarlyView.
ABSTRACT Background Educational access is key in empowering persons living with intellectual disabilities. Nevertheless, internationally, Persons with Intellectual Disabilities continue to experience marginalization and discrimination in accessing higher education.
Denise De Souza   +8 more
wiley   +1 more source

Collaborating in Surgery Through a Gendered Lens

open access: yes
ANZ Journal of Surgery, EarlyView.
Christobel Saunders, Mila Burnett
wiley   +1 more source

Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome [PDF]

open access: yesAmerican Journal of Medicine, 2021
In this paper we highlight the presence of tachycardia in post-acute COVID-19 syndrome by introducing a new label for this phenomenon-post-COVID-19 tachycardia syndrome-and argue that this constitutes a phenotype or sub-syndrome in post-acute COVID-19 syndrome.
Khalid Bin Thani   +2 more
exaly   +3 more sources

Post-COVID-19 asthenic syndrome

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021
To study the features of asthenic syndrome and the possibilities of its therapy in patients in the post-covid period.The study included 129 patients with an average age of 49.8±8.9 years who had undergone COVID-19 using a continuous sample method. Patients for the study were selected at the clinical bases of outpatient clinics in Samara (Russia) in ...
I A, Zolotovskaia   +3 more
openaire   +2 more sources

Ophthalmological manifestations of post-COVID-19 syndrome

Vestnik oftal'mologii, 2021
The review presents data on damage to the organ of vision in patients recovered from the new coronavirus infection reflecting on the results obtained by various researchers from examining patients with varying severity of the disease, both during the active stage and after recovery.
Yu N, Yusef   +3 more
openaire   +2 more sources

Post-COVID-19 neurologic syndrome

JAAPA, 2022
ABSTRACT COVID-19 quickly escalated to a global pandemic in 2020. As research on the topic continues, the medical community has found that this acute illness can cause a new chronic illness: postacute sequelae of SARS-CoV-2 (PASC). Some patients with PASC develop predominately neurologic sequelae (post-COVID-19 neurologic syndrome or PCNS ...
Joshua D, Luciew   +2 more
openaire   +2 more sources

Post-COVID-19 syndrome in a cohort of COVID-19

2023
- OBJECTIVE: The study aimed to investigate the frequency of post-COVID-19 syn-drome and associated factors in patients who visited the post-COVID-19 outpatient clinic after hospital discharge in the first, third, and sixth months of the first year of the pandemic. PATIENTS AND METHODS: The study was a clinical cohort study of patients hospitalized due
Bildirici, Yasar   +5 more
openaire   +1 more source

Post-COVID-19 syndrome and fibromyalgia

2023
A growing body of evidence is suggesting the possible subacute and long-term effects in patients suffering from COVID-19, affecting multiple organ systems. During acute COVID-19, musculoskeletal pain is reported in one-third of patients and it may be also part of the spectrum of post-COVID-19 syndrome, along with other manifestations.
Ursini F., Ruscitti P., Giacomelli R.
openaire   +1 more source

[Post-COVID-19 neuropsychological syndrome].

Revue medicale suisse, 2023
Recent observations suggest the persistence of neurological and neuropsychological symptoms in the long-term following SARS-CoV-2 infection. Currently described within the post-COVID-19 syndrome. The objective of this article is to discuss recent epidemiological data and data from neuroimaging studies. Finally, a discussion is proposed regarding recent
Philippe, Voruz   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy